ArticleBMC gastroenterology2023

Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patients.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.